Sanofi (SNY) Receivables - Net (2016 - 2025)
Sanofi's Receivables - Net history spans 11 years, with the latest figure at $9.8 billion for Q4 2025.
- For Q4 2025, Receivables - Net rose 19.33% year-over-year to $9.8 billion; the TTM value through Dec 2025 reached $9.8 billion, up 19.33%, while the annual FY2025 figure was $9.5 billion, 14.35% up from the prior year.
- Receivables - Net for Q4 2025 was $9.8 billion at Sanofi, up from $8.2 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $9.8 billion in Q4 2025 and bottomed at $8.2 billion in Q4 2024.
- The 5-year median for Receivables - Net is $8.7 billion (2021), against an average of $8.9 billion.
- The largest annual shift saw Receivables - Net decreased 9.59% in 2024 before it rose 19.33% in 2025.
- A 5-year view of Receivables - Net shows it stood at $8.7 billion in 2021, then decreased by 0.73% to $8.6 billion in 2022, then rose by 5.57% to $9.1 billion in 2023, then decreased by 9.59% to $8.2 billion in 2024, then grew by 19.33% to $9.8 billion in 2025.
- Per Business Quant, the three most recent readings for SNY's Receivables - Net are $9.8 billion (Q4 2025), $8.2 billion (Q4 2024), and $9.1 billion (Q4 2023).